• Bold and Bountiful

  Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics

  Kripa Mahalingam - July 11, 2017

• Early Mover

  What makes Intas the most valuable privately-held pharma company in India

  Krishna Gopalan - June 09, 2017

• Much-needed restorative

  Billionaire investor John Paulson comes to the rescue of the drugmaker Mylan with a 7-million-share purchase

  Team Outlook Business - June 16, 2015

• A new prescription

  Tectonic changes in the US generic drugs market is causing  huge shifts in Indian pharma’s strategies as well 

  Team Outlook Business - December 17, 2015